Bio/Pharma Business

Able Interim Chief Resigns Amid Drug Recall

Singapore is competing aggressively with India and China for a piece of the Asian sourcing business.

Schering AG To Cut Plants and Staff

Wyeth and Purdue Announce Restructuring Plans

Eli Lilly Scales Back Planned Virginia Insulin Plant

A myopic focus on short-term growth can endanger the community. The question is, can we enlighten our self-interest before the edifice falls down around our ears?

The Chapter 11 bankruptcy filing of aaiPharma (Wilmington, NC, www.aaipharma.com), parent of AAI Development Services, was the culmination of an agonizing year-long odyssey. It also was a first step in restoring one of the best-known brands in the CRO industry.

New Graduate Program Focuses On Pharmaceutical Technology

Pharmaceutical Technology has joined with INTERPHEX to found GenerationNext, an award program to recognize emerging leaders in pharmaceutical science and technology.

Crucell and NIH Sign Ebola Vaccine Manufacturing Contract

Pfizer Announces $4B/Year Cutbacks

Managers of FDA-regulated firms must be proactive in how they manage their company?s compliance with good manufacturing practices regulations.

Achieving the promised benefits of offshore sourcing to India and China is more complicated than it seems.

Innovators and generics makers are staking out positions on follow-on proteins and other manufacturing issues.

Managers of FDA-regulated firms must be proactive in how they manage their company's compliance with good manufacturing practices regulations.

Shortages of Key Drugs

After a five-year downturn, cautious optimism is taking hold among API manufacturers.

This article outlines a comprehensive approach for organizing a firm's aseptic operations, including planning for routine and nonroutine interventions, establishing effective process simulations, and determining which vials to incubate.

Novartis to Expand Generics Hold

GlaxoSmithKline Rebrands AIDS Drugs

Too many players and threats to the main customer base challenge European dose manufacturers.

Laser-Marking Technique Improves Tablet Branding

Committees make prudent decisions and avoid mistakes, but they're afraid of the new.

Patheon is betting the whole is worth more than the sum of the parts in its acquisition of Puerto Rico contract manufacturer Mova.

Pat Survey

The blockage in the new product pipeline may be breaking. CROs report increased demand for late-stage development services in their latest round of earnings reports.

More than 1500 pharmaceutical industry employees worldwide provide a personal view into the issues that matter most in the workforce, including salary and benefits, skills and education, and perspectives on the current job market.

What should pharmaceutical companies make of recent corporate developments at several high-profile service providers?

Pharmaceutical science and technology news